This presentation was given at last year's Market Access USA conference by Dr Michael Kulig, PhD, MPH, Scientific Advisor, Medical Consultancy Department.
Download the presentation to learn:
AMNOG Overview (G-BA perspective)
Current Issues (G-BA perspective)
-Patient-relevant endpoints
-Orphan drugs
-Existing market
Impact of assessments and resolutions